IPO fever is sweeping through the psychedelics space.
Articles
Survey Shows Support For Marijuana Legalization Among South Dakota Voters
Could marijuana legalization be on its way to South Dakota? As if 2020 couldn’t get any stranger, a new poll suggests that voters in the Mount Rushmore State could be ready to take the leap.
New Marijuana Coalition Unveils Plan To Legalize Interstate Cannabis Commerce
A coalition of advocacy groups and marijuana businesses have unveiled a unique plan to legalize interstate cannabis commerce regardless of ongoing federal prohibition.
MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor
MindMed Inc has applied to up-list on the NASDAQ.
Numinus Announces Listing of Warrants
Numinus warrants have an exercise price of CAD$0.35 and are valid until September 10, 2022.
Revive Therapeutics Provides Corporate Update on its Psychedelics Therapeutics Programs
Revive's corporate update centers on psilocybin research on a new delivery system and addiction treatment.
Texas Ban On Smokable Hemp Lifted Until 2021, Judge Rules
A Texas ban on smokable hemp products hit another roadblock in court last week when a state judge barred officials from enforcing the prohibition until an industry challenge can be heard in court.
Nebraska Activists Submit 15k Signatures to Establish ‘Legal Marijuana Now’ Party
Nebraska activists have turned in 15,000 signatures to establish the Legal Marijuana Now party in the state, four years after falling short due to a lack of valid signatures, the Lincoln Journal-Star reports.
Cannabis-based packaging and paper could reduce waste, promote sustainability
Cannabis businesses have long struggled with the excessive packaging their products are required to use, employing extra layers of plastic and paper to ensure that flower or vape products are childproof and don’t fall into the wrong hands.
Mind Cure Targets Multi-Billion Dollar Sweet-Spot in Life Sciences
The road to psychedelic drug success leads through functional mushrooms.
Why Canada Is The Natural Launch-Pad For The Psychedelic Drug Industry
Canada stands out as the premier destination for psychedelic drug companies.
An Investing Roadmap For The Mental Health Crisis
A $225 billion treatment market is badly in need of new therapies. Here is the roadmap for investors to capitalize on this opportunity.
Compass’s Upsized IPO Financing Sends ‘Buy’ Signal For Sector
Compass has boosted its IPO financing by roughly 20% AND increased the unit price -- signalling strong interest in the psychedelic space.
Mind Cure Announces Closing of Oversubscribed Upsized Initial Public Offering
Newest IPO hits September 21- MCUR